ArticleEuropean journal of medical research2025
Identification and validation of key genes related to apoptosis in multiple organ dysfunction syndrome.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Revealing the Diagnostic Potential of Three RHO GTPase-Related Genes in Osteoarthritis Based on Single-Cell RNA Sequencing and GEO Dataset Analysis.International journal of genomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundApoptosis occupies a core position in the pathogenesis of multiple organ dysfunction syndrome (MODS). Therefore, exploring key mechanisms of action of apoptosis-related genes (ARGs) in MODS will play a positive and promoting role in the diagnosis and treatment of MODS.
methodsWe obtained MODS-related data from public databases, and analyzed the disparately expressed genes between MODS and controls, as well as the weighted gene co-expression network analysis (WGCNA) genes most related to MODS. The intersection with ARGs was then used to obtain candidate genes. After that, by combining Cytoscape software, machine learning algorithms with expression verification, key genes were obtained, and a nomogram model was constructed and evaluated. Next, centering on key genes, gene set enrichment analysis, immune infiltration analysis, small ubiquitin-like modifier (SUMO) analysis, regulatory network construction, and drug prediction were carried out. At last, the expression of key genes in clinical samples was validated.
resultsAfter screening, S100A9, S100A8, and BCL2A1 were identified as the key genes of MODS. They were all significantly highly expressed in MODS and jointly participated in "oxidative phosphorylation" signaling pathway. The nomogram constructed based on the key genes had excellent predictive ability. There were 15 types of differentially infiltrated immune cells between MODS and controls, and they were correlated with the key genes. In addition, each of the key genes had two or more SUMOylation sites, and multiple miRNAs (hsa-let-7d-5p) and lncRNAs (XIST) were predicted. Subsequently, the key genes also jointly predicted potential drugs (curcumin). Finally, in clinical samples of MODS, the key genes also showed high expression.
conclusionS100A9, S100A8, and BCL2A1 were the key genes of MODS in terms of apoptosis. The constructed nomogram had an excellent predictive value. It offers a novel approach and potential targeted therapy for the clinical diagnosis and treatment of MODS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.